Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2012
10/24/2012EP2512498A2 Peptide protection against ultraviolet light toxicity
10/24/2012EP2512496A1 Peptide
10/24/2012CN102753567A Mybl2 peptides and vaccines containing the same
10/24/2012CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof
10/24/2012CN102746385A Thymosin alpha 1 active fragment cyclopeptide analogue and polyethylene glycol derivative thereof
10/24/2012CN102746384A High purity caspofungin or its salt and its preparation method and application
10/24/2012CN102746383A Synthesis method of goserelin
10/24/2012CN102746382A B-cell epitope peptide of heart fatty acid binding protein (H-FABP), antibody and applications thereof
10/24/2012CN102746381A Helicobacter pylori antigen HLA restrictive immunodominance epitope peptide and preparation method and application thereof
10/24/2012CN102746380A Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis
10/24/2012CN102746379A Polypeptide
10/24/2012CN102746378A Anti-fatty acid synthetase polypeptide and its application
10/24/2012CN102746377A Epitope peptide of mycobacterium trberculosis protein antigen, and its application
10/24/2012CN102746376A Cyclopeptide antibiotics and preparation method thereof and application of cylopeptide antibiotics in preparation of antibacterial agents
10/24/2012CN101575362B Cyclic pentapeptide human elastase inhibitor and preparation method thereof
10/23/2012US8293870 Mucin hypersecretion inhibitors and methods of use
10/23/2012US8293704 Crystalline form of linaclotide
10/23/2012US8293703 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/23/2012US8293702 Phenolic binding peptides
10/23/2012CA2488127C Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2373475C Novel cyanine and indocyanine dye bioconjugates for biomedical applications
10/18/2012WO2012141201A1 Peptide for cancer immunotherapy and method using same
10/18/2012WO2012140500A1 Selective cysteine protease inhibitors and uses thereof
10/18/2012WO2012140331A1 Novel activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same
10/18/2012WO2012139519A1 Cyclic peptide and medical use thereof
10/18/2012WO2012139179A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
10/18/2012WO2012100176A3 Macrocyclic compounds with a hybrid peptidic/non-peptidic backbone and methods for their preparation
10/18/2012WO2012095388A3 Compounds for treatment of feline leukemia in felidae
10/18/2012WO2011115812A8 Affinity peptides toward bmp-2
10/18/2012US20120264912 Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/18/2012US20120264693 Compounds acting as peptide gap junction modulators, and uses thereof
10/18/2012US20120264685 Short chain peptidomimetics based orally active glp 1 agonist and glucagon receptor antagonist
10/18/2012US20120264679 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120264156 Method for Characterizing At Least One Microorganism By Means Of Mass Spectrometry
10/18/2012US20120264147 Diagnostic Marker for Hepatocellular Carcinoma Comprising Anti-FASN Autoantibodies and a Diagnostic Composition for Hepatocellular Carcinoma Comprising Antigens Thereof
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263688 Rumc peptides with antimicrobial activity
10/18/2012US20120263665 Peptide
10/18/2012US20120263654 Melanoma specific biomarker
10/18/2012CA2833082A1 Selective cysteine protease inhibitors and uses thereof
10/17/2012EP2511371A1 Anticancer anti-mortalin peptide antibodies
10/17/2012EP2510936A1 Calcium binding peptides
10/17/2012EP2510935A1 Calcium binding peptides
10/17/2012EP2510919A2 Oleanoyl peptide composition and a method of treating skin aging
10/17/2012EP2510097A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/17/2012EP2509992A2 Treatments for gastrointestinal disorders
10/17/2012EP2509615A1 Novel cyclic peptides
10/17/2012CN102741276A Synthetic myostatin peptide antagonists
10/17/2012CN102741272A Peptides inhibiting adhesion of aspergillus fumigatus to cornea
10/17/2012CN102741271A IMP-3 oligopeptides and vaccines including the same
10/17/2012CN102731627A Solid-phase synthesis method of Cilengitide
10/17/2012CN102731626A Cyclopeptide and its medicinal application
10/17/2012CN102731625A Method for purifying terli
10/17/2012CN102731624A Method for synthesis of bivalirudin in solid-phase fragment approach
10/17/2012CN102731623A Murine original monoclonal antibody 3D8 identified hantaan virus glycoprotein neutralizing epitope peptide and application thereof
10/17/2012CN102731622A Quantum dot-phage complex of specific targeting human embryonic stem cell
10/17/2012CN102731621A Peptide segment of specific targeting human embryonic stem cell and application thereof
10/17/2012CN102731620A Peptide segment of specific targeting human embryonic stem cell
10/17/2012CN102731619A Peptide of specific target human embryonic stem cell
10/17/2012CN102731618A Peptide of specific target human embryonic stem cell, and its application
10/17/2012CN102731617A Hantaan virus glucoprotein specific T cell epitope peptide and application thereof
10/17/2012CN102731616A Tetanus-toxin-neutralizing B cell epitope peptide and application thereof
10/17/2012CN102731615A Detection reagent and detection method for PRRSV
10/17/2012CN101906149B Linear polypeptide and synthetic method and application thereof
10/17/2012CN101684145B Antigen peptide identified by p53 antoantibody, kit and application thereof in preparing tumor detection kit
10/16/2012US8288510 Isolated peptides having phospholipase inhibitory activity
10/16/2012US8288509 Therapeutic agent for infections, and treatment method using the same
10/16/2012US8288351 Antagonists of the bradykinin B1 receptor
10/16/2012US8288345 Treating stroke and other diseases without inhibiting N-type calcium channels
10/16/2012US8288336 Treatment of subarachnoid hemorrhage with ApoE analogs
10/16/2012US8288335 ApoE analogs and methods for their use
10/16/2012US8288334 Peptides for wound healing
10/16/2012US8288130 Polypeptide cleavage process
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2453202C Peptides which modulate blood coagulation and methods of use thereof
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012138294A1 Novel peptides that bind to types of mhc class ii and their use on diagnosis and treatment
10/11/2012WO2012138251A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors
10/11/2012WO2012137538A1 Cytotoxic t cell inducing composition
10/11/2012WO2012137150A2 Cell penetrating peptides for intracellular delivery of molecules
10/11/2012WO2012136498A1 Methods for manufacturing an antifungal agent
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012118444A9 Novel compounds with photoluminescnce properties and applications thereof
10/11/2012US20120259091 Apolipoprotein A1 Mimetics and Uses Thereof
10/11/2012US20120258920 Peptides and aptamers thereof as specific modulators of mutant p53 function
10/11/2012US20120258918 Polypeptoid pulmonary surfactants
10/11/2012US20120258550 Regulation of autophagy pathway phosphorylation and uses thereof
10/11/2012US20120258127 Vaccine peptides
10/11/2012US20120258111 Compositions and methods for modulating rsv infection and immunity
10/11/2012US20120258077 Human M2e Peptide Immunogens
10/11/2012US20120258043 Linkable Lewis X Analogs
10/11/2012DE112009003659T5 Mittel zur Beseitigung einer Multiarzneimitelresistenz Means for removing a multidrug resistance Mitel
10/11/2012CA2833425A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012CA2829511A1 Methods for manufacturing an antifungal agent
10/10/2012EP2508601A2 Tem8 peptides and vaccines comprising the same
10/10/2012EP2508531A1 Stitched polypeptides
10/10/2012EP2507637A1 Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 423